Boston Scientific (BSX) Invested Capital (2009 - 2026)

Boston Scientific's Invested Capital history runs 18 years deep, the most recent figure standing at $26.5 billion for Q1 2026.

• In Q1 2026, Invested Capital fell 21.63% year-over-year to $26.5 billion; the TTM figure through Mar 2026 stood at $26.5 billion (down 21.63% YoY), while the FY2025 annual figure was $24.7 billion, up 13.38% from the prior year.
• Invested Capital came in at $26.5 billion for Q1 2026 at Boston Scientific, up from $24.7 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $35.2 billion in Q3 2025 to a low of -$60.0 million in Q2 2025.
• A 5-year average of $19.3 billion and a median of $23.3 billion in 2022 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 1033.94% in 2023 and tumbled 100.56% in 2025, its largest moves.
• Boston Scientific's Invested Capital stood at $2.5 billion in 2022, then jumped by 1033.94% to $28.6 billion in 2023, then fell by 23.97% to $21.8 billion in 2024, then grew by 13.38% to $24.7 billion in 2025, then grew by 7.17% to $26.5 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $26.5 billion, $24.7 billion, and $35.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison